drugset / Trial / NCT00098605
Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases
NaSingle-groupOpen-labelTreatment
Summary
Lapatinib may stop the growth of tumor cells by blocking some of the enzymes needed for their growth. This phase II trial is studying how well lapatinib works in treating brain metastases in patients with stage IV breast cancer and brain metastases.
Timeline
- Start
- 2004-10
- Primary completion
- 2006-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lapatinib | Small molecule | 750 mg | Oral |